drugset / Trial / NCT05166668
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study To compare the clinical and laboratory outcomes of two ovarian stimulation protocols (standard GnRH antagonist protocol and aromatase inhibitor/ antagonist protocol) in women (40-44) years undergoing ICSI cycle.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2025-02-10
- Completion
- 2025-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Letrozole | Other / unclassified | 2.5 mg | Oral |